Matthew E. Korenberg is President & COO at LIGAND PHARMACEUTICALS INC (LGND). They have made 7 open-market trades across 1 company since 2017, most recently 2026-06-12.
CIK 0001649903
1 open-market purchase totalling $43K since 2019, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LGND | SELL | 2024-09-20 | 2024-09-24 | $102.35 | $3.3M | +5.7% | +11.9% | +14.8% |
| LGND | SELL | 2024-08-22 | 2024-08-26 | $105.34 | $4.0M | -3.3% | -5.5% | +15.3% |
| LGND | SELL | 2024-08-09 | 2024-08-13 | $98.50 | $3.6M | +1.2% | -0.5% | +20.3% |
| LGND | SELL | 2024-05-13 | 2024-05-15 | $84.98 | $2.9M | +0.7% | -6.3% | +20.6% |
| LGND | BUY | 2019-09-03 | 2019-09-03 | $86.18 | $43K | +9.2% | +14.1% | +24.9% |
| LGND | SELL | 2018-08-29 | 2018-08-29 | $256.69 | $9.4M | +1.1% | +7.3% | -39.2% |
| LGND | SELL | 2017-11-17 | 2017-11-17 | $142.63 | $1.9M | -3.1% | +0.8% | +15.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.